Allogeneic Transplantation for Myelofibrosis with Novel Graft-versus-Host Disease Prophylaxis

Acta Haematol. 2021;144(2):124-125. doi: 10.1159/000508198. Epub 2020 Jun 22.

Authors

Leonid Volodin¹, Karen K Ballen²

Affiliations

¹ Division of Hematology/Oncology, University of Virginia Cancer Center, Charlottesville, Virginia, USA, lv2n@virginia.edu.
² Division of Hematology/Oncology, University of Virginia Cancer Center, Charlottesville, Virginia, USA.

PMID: 32570245
DOI: 10.1159/000508198

No abstract available

Publication types

Comment

MeSH terms

Cyclophosphamide
Graft vs Host Disease* / etiology
Graft vs Host Disease* / prevention & control
Humans
Nitriles
Pilot Projects
Primary Myelofibrosis* / therapy
Prospective Studies
Pyrazoles
Pyrimidines
Transplantation, Homologous

Substances

Nitriles
Pyrazoles
Pyrimidines
ruxolitinib
Cyclophosphamide